Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study.

Saved in:
Bibliographic Details
Title: Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study.
Authors: Wakai E; 1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.; 2Department of Clinical Pharmacy and Biopharmaceutics, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507 Japan., Ikemura K; 1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan., Sugimoto H; 1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan., Iwamoto T; 1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.; 2Department of Clinical Pharmacy and Biopharmaceutics, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507 Japan., Okuda M; 1Department of Pharmacy, Mie University Hospital, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.; 2Department of Clinical Pharmacy and Biopharmaceutics, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507 Japan.
Source: Journal of pharmaceutical health care and sciences [J Pharm Health Care Sci] 2019 Feb 13; Vol. 5, pp. 4. Date of Electronic Publication: 2019 Feb 13 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101672177 Publication Model: eCollection Cited Medium: Print ISSN: 2055-0294 (Print) Linking ISSN: 20550294 NLM ISO Abbreviation: J Pharm Health Care Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first